Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07217444 · ClinicalTrials.gov registry record · NA

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

A NA study of Suicidal Ideation and Major Depressive Disorder (MDD), sponsored by Children's Hospital Medical Center, Cincinnati.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07217444: Recruiting NA study of Suicidal Ideation and Major Depressive Disorder (MDD), sponsored by Children's Hospital Medical Center, Cincinnati.

NCT07217444 is a NA study of Suicidal Ideation and Major Depressive Disorder (MDD) that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 60 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07217444, a NA study of Suicidal Ideation and Major Depressive Disorder (MDD), is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Evaluate the feasibility, safety, and preliminary efficacy of deep Transcranial Magnetic Stimulation (dTMS) as an adjunctive treatment for adolescents hospitalized with major depressive disorder (MDD).

Primary Outcome

We will collect and summarize descriptive data on discomfort and adverse events using Sections IV of the TMS Adverse Events and Associated Sensations Questionnaire (TMSens\_Q). This captures typical sensory experiences or side effects, e.g. scalp tingling or headache) as well as adverse events (e.g. syncope). Tolerability will be characterized based on sensory experiences and side effects, comparing active to sham treatment. Safety will be further assessed by the rate of early discontinuation du

Interventions

  • DEVICE Transcranial Magnetic Stimulation
  • DEVICE Transcranial Magnetic Stimulation Sham

Study Locations (1)

Ohio

  • Cincinnati Childrens Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-11-13
Est. Completion 2026-12-30
Phase NA

What NCT07217444 shows while recruiting

NCT07217444 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (78% lower).

The record links to 3 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Magnetic Stimulation is the first listed.

NCT07217444 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT07217444 about?

NCT07217444 is a clinical study titled "Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation". Evaluate the feasibility, safety, and preliminary efficacy of deep Transcranial Magnetic Stimulation (dTMS) as an adjunctive treatment for adolescents hospitalized with major depressive disorder (MDD).

What is the current status of trial NCT07217444?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-11-13. Estimated completion is 2026-12-30.

What conditions does trial NCT07217444 study?

This clinical trial studies the following conditions: Suicidal Ideation, Major Depressive Disorder (MDD), Hospitalization in Children.

What interventions are being tested in trial NCT07217444?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE), Transcranial Magnetic Stimulation Sham (DEVICE).

Who is sponsoring clinical trial NCT07217444?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07217444 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07217444's enrollment target sits among peer trials

60 58th of 84 higher than 23 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07217444, the US trial registry maintained by the National Library of Medicine. NCT07217444 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.